カテゴリー： QYResearch, 世界

世界の神経内分泌腫瘍治療薬市場 2019年

【英語タイトル】Global Neuroendocrine Tumor Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X11951）・商品コード：DATA909X11951
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、神経内分泌腫瘍治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、mTORタンパク質阻害剤、チロシンキナーゼ3阻害剤、ソマトスタチン受容体拮抗薬、成長ホルモン放出因子拮抗薬、ソマトスタチン受容体作動薬、その他に、用途別には、病院、クリニック、その他にセグメント区分し、神経内分泌腫瘍治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・神経内分泌腫瘍治療薬の世界市場概要
・神経内分泌腫瘍治療薬の製造コスト構成分析
・神経内分泌腫瘍治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・神経内分泌腫瘍治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・神経内分泌腫瘍治療薬のセグメント分析（種類別）
（mTORタンパク質阻害剤、チロシンキナーゼ3阻害剤、ソマトスタチン受容体拮抗薬、成長ホルモン放出因子拮抗薬、ソマトスタチン受容体作動薬、その他）
・神経内分泌腫瘍治療薬のセグメント分析（用途別）
（病院、クリニック、その他）
・神経内分泌腫瘍治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Eisai、Exelixis, Inc.、Foresee Pharmaceuticals, LLC、Hutchison MediPharma Limited、Intezyne, Inc、INVENT Pharmaceuticals, Inc.、Ipsen S.A.、Jiangsu Hengrui Medicine Co., Ltd.、Karyopharm Therapeutics, Inc.、Lexicon Pharmaceuticals, Inc.、Midatech Pharma Plc .、Millennium Pharmaceuticals, Inc.、MolMed S.p.A.、Northwest Biotherapeutics, Inc.、Novartis AG、OctreoPharm Sciences GmbH、OXiGENE, Inc.、）
・神経内分泌腫瘍治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Neuroendocrine Tumor Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Neuroendocrine Tumor Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroendocrine Tumor Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neuroendocrine Tumor Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neuroendocrine Tumor Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Eisai
Exelixis, Inc.
Foresee Pharmaceuticals, LLC
Hutchison MediPharma Limited
Intezyne, Inc
INVENT Pharmaceuticals, Inc.
Ipsen S.A.
Jiangsu Hengrui Medicine Co., Ltd.
Karyopharm Therapeutics, Inc.
Lexicon Pharmaceuticals, Inc.
Midatech Pharma Plc .
Millennium Pharmaceuticals, Inc.
MolMed S.p.A.
Northwest Biotherapeutics, Inc.
Novartis AG
OctreoPharm Sciences GmbH
OXiGENE, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
mTOR protein inhibitors
Tyrosine kinase 3 inhibitors
Somatostatin receptor antagonists
Growth hormone releasing factor antagonists
Somatostatin receptor agonists
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Neuroendocrine Tumor Drug
1.1 Definition of Neuroendocrine Tumor Drug
1.2 Neuroendocrine Tumor Drug Segment by Type
1.2.1 Global Neuroendocrine Tumor Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 mTOR protein inhibitors
1.2.3 Tyrosine kinase 3 inhibitors
1.2.4 Somatostatin receptor antagonists
1.2.5 Growth hormone releasing factor antagonists
1.2.6 Somatostatin receptor agonists
1.2.7 Others
1.3 Neuroendocrine Tumor Drug Segment by Applications
1.3.1 Global Neuroendocrine Tumor Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Neuroendocrine Tumor Drug Overall Market
1.4.1 Global Neuroendocrine Tumor Drug Revenue (2014-2025)
1.4.2 Global Neuroendocrine Tumor Drug Production (2014-2025)
1.4.3 North America Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
1.4.4 Europe Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
1.4.5 China Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
1.4.6 Japan Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
1.4.8 India Neuroendocrine Tumor Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neuroendocrine Tumor Drug
2.3 Manufacturing Process Analysis of Neuroendocrine Tumor Drug
2.4 Industry Chain Structure of Neuroendocrine Tumor Drug

3 Development and Manufacturing Plants Analysis of Neuroendocrine Tumor Drug
3.1 Capacity and Commercial Production Date
3.2 Global Neuroendocrine Tumor Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Neuroendocrine Tumor Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Neuroendocrine Tumor Drug Production and Capacity Analysis
4.2 Neuroendocrine Tumor Drug Revenue Analysis
4.3 Neuroendocrine Tumor Drug Price Analysis
4.4 Market Concentration Degree

5 Neuroendocrine Tumor Drug Regional Market Analysis
5.1 Neuroendocrine Tumor Drug Production by Regions
5.1.1 Global Neuroendocrine Tumor Drug Production by Regions
5.1.2 Global Neuroendocrine Tumor Drug Revenue by Regions
5.2 Neuroendocrine Tumor Drug Consumption by Regions
5.3 North America Neuroendocrine Tumor Drug Market Analysis
5.3.1 North America Neuroendocrine Tumor Drug Production
5.3.2 North America Neuroendocrine Tumor Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Neuroendocrine Tumor Drug Import and Export
5.4 Europe Neuroendocrine Tumor Drug Market Analysis
5.4.1 Europe Neuroendocrine Tumor Drug Production
5.4.2 Europe Neuroendocrine Tumor Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Neuroendocrine Tumor Drug Import and Export
5.5 China Neuroendocrine Tumor Drug Market Analysis
5.5.1 China Neuroendocrine Tumor Drug Production
5.5.2 China Neuroendocrine Tumor Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Neuroendocrine Tumor Drug Import and Export
5.6 Japan Neuroendocrine Tumor Drug Market Analysis
5.6.1 Japan Neuroendocrine Tumor Drug Production
5.6.2 Japan Neuroendocrine Tumor Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Neuroendocrine Tumor Drug Import and Export
5.7 Southeast Asia Neuroendocrine Tumor Drug Market Analysis
5.7.1 Southeast Asia Neuroendocrine Tumor Drug Production
5.7.2 Southeast Asia Neuroendocrine Tumor Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Neuroendocrine Tumor Drug Import and Export
5.8 India Neuroendocrine Tumor Drug Market Analysis
5.8.1 India Neuroendocrine Tumor Drug Production
5.8.2 India Neuroendocrine Tumor Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Neuroendocrine Tumor Drug Import and Export

6 Neuroendocrine Tumor Drug Segment Market Analysis (by Type)
6.1 Global Neuroendocrine Tumor Drug Production by Type
6.2 Global Neuroendocrine Tumor Drug Revenue by Type
6.3 Neuroendocrine Tumor Drug Price by Type

7 Neuroendocrine Tumor Drug Segment Market Analysis (by Application)
7.1 Global Neuroendocrine Tumor Drug Consumption by Application
7.2 Global Neuroendocrine Tumor Drug Consumption Market Share by Application (2014-2019)

8 Neuroendocrine Tumor Drug Major Manufacturers Analysis
8.1 Eisai
8.1.1 Eisai Neuroendocrine Tumor Drug Production Sites and Area Served
8.1.2 Eisai Product Introduction, Application and Specification
8.1.3 Eisai Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Exelixis, Inc.
8.2.1 Exelixis, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
8.2.2 Exelixis, Inc. Product Introduction, Application and Specification
8.2.3 Exelixis, Inc. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Foresee Pharmaceuticals, LLC
8.3.1 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Sites and Area Served
8.3.2 Foresee Pharmaceuticals, LLC Product Introduction, Application and Specification
8.3.3 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Hutchison MediPharma Limited
8.4.1 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Sites and Area Served
8.4.2 Hutchison MediPharma Limited Product Introduction, Application and Specification
8.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Intezyne, Inc
8.5.1 Intezyne, Inc Neuroendocrine Tumor Drug Production Sites and Area Served
8.5.2 Intezyne, Inc Product Introduction, Application and Specification
8.5.3 Intezyne, Inc Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 INVENT Pharmaceuticals, Inc.
8.6.1 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
8.6.2 INVENT Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.6.3 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Ipsen S.A.
8.7.1 Ipsen S.A. Neuroendocrine Tumor Drug Production Sites and Area Served
8.7.2 Ipsen S.A. Product Introduction, Application and Specification
8.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Jiangsu Hengrui Medicine Co., Ltd.
8.8.1 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Sites and Area Served
8.8.2 Jiangsu Hengrui Medicine Co., Ltd. Product Introduction, Application and Specification
8.8.3 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Karyopharm Therapeutics, Inc.
8.9.1 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
8.9.2 Karyopharm Therapeutics, Inc. Product Introduction, Application and Specification
8.9.3 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Lexicon Pharmaceuticals, Inc.
8.10.1 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
8.10.2 Lexicon Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.10.3 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Midatech Pharma Plc .
8.12 Millennium Pharmaceuticals, Inc.
8.13 MolMed S.p.A.
8.14 Northwest Biotherapeutics, Inc.
8.15 Novartis AG
8.16 OctreoPharm Sciences GmbH
8.17 OXiGENE, Inc.

9 Development Trend of Analysis of Neuroendocrine Tumor Drug Market
9.1 Global Neuroendocrine Tumor Drug Market Trend Analysis
9.1.1 Global Neuroendocrine Tumor Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Neuroendocrine Tumor Drug Regional Market Trend
9.2.1 North America Neuroendocrine Tumor Drug Forecast 2019-2025
9.2.2 Europe Neuroendocrine Tumor Drug Forecast 2019-2025
9.2.3 China Neuroendocrine Tumor Drug Forecast 2019-2025
9.2.4 Japan Neuroendocrine Tumor Drug Forecast 2019-2025
9.2.5 Southeast Asia Neuroendocrine Tumor Drug Forecast 2019-2025
9.2.6 India Neuroendocrine Tumor Drug Forecast 2019-2025
9.3 Neuroendocrine Tumor Drug Market Trend (Product Type)
9.4 Neuroendocrine Tumor Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Neuroendocrine Tumor Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Neuroendocrine Tumor Drug
Table Global Neuroendocrine Tumor Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Neuroendocrine Tumor Drug Production Market Share by Types in 2018
Figure mTOR protein inhibitors Product Picture
Figure Tyrosine kinase 3 inhibitors Product Picture
Figure Somatostatin receptor antagonists Product Picture
Figure Growth hormone releasing factor antagonists Product Picture
Figure Somatostatin receptor agonists Product Picture
Figure Others Product Picture
Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Neuroendocrine Tumor Drug Revenue (Million USD) (2014-2025)
Figure Global Neuroendocrine Tumor Drug Production (K Pcs) (2014-2025)
Figure North America Neuroendocrine Tumor Drug Market Size (Million USD) (2014-2025)
Figure Europe Neuroendocrine Tumor Drug Market Size (Million USD) (2014-2025)
Figure China Neuroendocrine Tumor Drug Market Size (Million USD) (2014-2025)
Figure Japan Neuroendocrine Tumor Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Neuroendocrine Tumor Drug Market Size (Million USD) (2014-2025)
Figure India Neuroendocrine Tumor Drug Market Size (Million USD) (2014-2025)
Table Neuroendocrine Tumor Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neuroendocrine Tumor Drug in 2018
Figure Manufacturing Process Analysis of Neuroendocrine Tumor Drug
Figure Industry Chain Structure of Neuroendocrine Tumor Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Neuroendocrine Tumor Drug Manufacturing Plants Distribution
Table Neuroendocrine Tumor Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Neuroendocrine Tumor Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Neuroendocrine Tumor Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Neuroendocrine Tumor Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Neuroendocrine Tumor Drug Production Share by Manufacturers in 2018
Table Neuroendocrine Tumor Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Neuroendocrine Tumor Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Neuroendocrine Tumor Drug Revenue Share by Manufacturers in 2018
Table Neuroendocrine Tumor Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Neuroendocrine Tumor Drug Production by Regions 2014-2019 (K Pcs)
Table Global Neuroendocrine Tumor Drug Production Market Share by Regions 2014-2019
Figure Global Neuroendocrine Tumor Drug Production Market Share by Regions in 2018
Table Global Neuroendocrine Tumor Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Neuroendocrine Tumor Drug Revenue Market Share by Regions 2014-2019
Figure Global Neuroendocrine Tumor Drug Revenue Market Share by Regions in 2018
Table Global Neuroendocrine Tumor Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Neuroendocrine Tumor Drug Consumption Market Share by Regions 2014-2019
Figure North America Neuroendocrine Tumor Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Neuroendocrine Tumor Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Neuroendocrine Tumor Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Neuroendocrine Tumor Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Neuroendocrine Tumor Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Neuroendocrine Tumor Drug Production, Consumption Import and Export (K Pcs)
Figure China Neuroendocrine Tumor Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Neuroendocrine Tumor Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Neuroendocrine Tumor Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Neuroendocrine Tumor Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Neuroendocrine Tumor Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Neuroendocrine Tumor Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Neuroendocrine Tumor Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Neuroendocrine Tumor Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Neuroendocrine Tumor Drug Production, Consumption Import and Export (K Pcs)
Figure India Neuroendocrine Tumor Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Neuroendocrine Tumor Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Neuroendocrine Tumor Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Neuroendocrine Tumor Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Neuroendocrine Tumor Drug Market Share by Application (2014-2019)
Table Eisai Neuroendocrine Tumor Drug Production Sites and Area Served
Table Eisai Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Eisai Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Eisai Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Eisai Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Eisai Neuroendocrine Tumor Drug Main Business and Markets Served
Table Exelixis, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
Table Exelixis, Inc. Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Exelixis, Inc. Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Exelixis, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Exelixis, Inc. Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Exelixis, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Exelixis, Inc. Neuroendocrine Tumor Drug Main Business and Markets Served
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Sites and Area Served
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Main Business and Markets Served
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Sites and Area Served
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Main Business and Markets Served
Table Intezyne, Inc Neuroendocrine Tumor Drug Production Sites and Area Served
Table Intezyne, Inc Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Intezyne, Inc Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Intezyne, Inc Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Intezyne, Inc Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Intezyne, Inc Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Intezyne, Inc Neuroendocrine Tumor Drug Main Business and Markets Served
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Main Business and Markets Served
Table Ipsen S.A. Neuroendocrine Tumor Drug Production Sites and Area Served
Table Ipsen S.A. Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Ipsen S.A. Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ipsen S.A. Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Ipsen S.A. Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Ipsen S.A. Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Ipsen S.A. Neuroendocrine Tumor Drug Main Business and Markets Served
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Sites and Area Served
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Main Business and Markets Served
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Main Business and Markets Served
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Product Introduction, Application and Specification
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Market Share (2014-2019)
Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2014-2019)
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Main Business and Markets Served
Table Midatech Pharma Plc . Neuroendocrine Tumor Drug Production Sites and Area Served
Table Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
Table MolMed S.p.A. Neuroendocrine Tumor Drug Production Sites and Area Served
Table Northwest Biotherapeutics, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
Table Novartis AG Neuroendocrine Tumor Drug Production Sites and Area Served
Table OctreoPharm Sciences GmbH Neuroendocrine Tumor Drug Production Sites and Area Served
Table OXiGENE, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
Figure Global Neuroendocrine Tumor Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Neuroendocrine Tumor Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Neuroendocrine Tumor Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Neuroendocrine Tumor Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Neuroendocrine Tumor Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Neuroendocrine Tumor Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Neuroendocrine Tumor Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Neuroendocrine Tumor Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Neuroendocrine Tumor Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Neuroendocrine Tumor Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Neuroendocrine Tumor Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Neuroendocrine Tumor Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Neuroendocrine Tumor Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Neuroendocrine Tumor Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Neuroendocrine Tumor Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Neuroendocrine Tumor Drug by Application (2019-2025)
Table Neuroendocrine Tumor Drug Distributors List
Table Neuroendocrine Tumor Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Eisai、Exelixis, Inc.、Foresee Pharmaceuticals, LLC、Hutchison MediPharma Limited、Intezyne, Inc、INVENT Pharmaceuticals, Inc.、Ipsen S.A.、Jiangsu Hengrui Medicine Co., Ltd.、Karyopharm Therapeutics, Inc.、Lexicon Pharmaceuticals, Inc.、Midatech Pharma Plc .、Millennium Pharmaceuticals, Inc.、MolMed S.p.A.、Northwest Biotherapeutics, Inc.、Novartis AG、OctreoPharm Sciences GmbH、OXiGENE, Inc.、

★調査レポート[世界の神経内分泌腫瘍治療薬市場 2019年] (コード：DATA909X11951)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の神経内分泌腫瘍治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 神経内分泌腫瘍治療の世界市場：規模・現状・予測2019-2025
    DATA909X18748 / QYResearch / 2019年11月25日 / ※当調査レポートでは、神経内分泌腫瘍治療の世界市場について調査・分析し、神経内分泌腫瘍治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（エベロリムス、スニチニブ、ルタタテート、ランレオチド、オクトレオチド）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の神経内分泌腫瘍治療市場動向 ・主要企業別マーケットシェア ・神経内分泌腫瘍治療の種類別市場規模2014-2019 （エベロリムス、スニチニブ、ルタタテート、ランレオチド、オクトレオチド） ・神経内分泌腫瘍治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・神経内分泌腫瘍治療の北米市場：主要企業・種類別/用途別市場規模 ・神経内分泌腫瘍治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body.In 2018, the global Neuroendocrine Tumor Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Neuroendocrine Tumor Treatment status, future forecast, growth opportunity, key market and...
  • 世界の転移性骨腫瘍治療市場 2019年
    DATA909X11319 / QYResearch / 2019年11月20日 / ※本調査レポートは、転移性骨腫瘍治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、外照射療法、化学療法、ホルモン療法、免疫療法、薬物療法、外科的治療に、用途別には、病院、がんリハビリテーションセンター、専門クリニック、外来手術センターにセグメント区分し、転移性骨腫瘍治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・転移性骨腫瘍治療の世界市場概要 ・転移性骨腫瘍治療の製造コスト構成分析 ・転移性骨腫瘍治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・転移性骨腫瘍治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・転移性骨腫瘍治療のセグメント分析（種類別） （外照射療法、化学療法、ホルモン療法、免疫療法、薬物療法、外科的治療）...The global Metastatic Bone Tumor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Metastatic Bone Tumor Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metastatic Bone Tumor Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Metastatic Bone Tumor Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のウィルムス腫瘍タンパク質市場 2019年
    DATA909X17797 / QYResearch / 2019年11月22日 / ※本調査レポートは、ウィルムス腫瘍タンパク質の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Elatipepimut-S、Galinpepimut-S、GSK-2130579A、INO-5401、OCV-501、その他に、用途別には、副腎がん、高悪性度神経膠腫、肺がん、腹膜がん、その他にセグメント区分し、ウィルムス腫瘍タンパク質の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ウィルムス腫瘍タンパク質の世界市場概要 ・ウィルムス腫瘍タンパク質の製造コスト構成分析 ・ウィルムス腫瘍タンパク質の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ウィルムス腫瘍タンパク質の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ウィルムス腫瘍タンパク質のセグメント分析（種類別） （Elatipepimut-S、Galinpepimut-S、GSK-2130579A、INO-5401、OCV-501、その他）...The global Wilms Tumor Protein market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Wilms Tumor Protein volume and value at global level, regional level and company level. From a global perspective, this report represents overall Wilms Tumor Protein market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Wilms Tumor Protein in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の細胞性腫瘍抗原p53市場 2019年
    DATA909X05261 / QYResearch / 2019年11月15日 / ※本調査レポートは、細胞性腫瘍抗原p53の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他に、用途別には、卵巣がん、前立腺がん、脳がん、その他にセグメント区分し、細胞性腫瘍抗原p53の世界市場を分析しました。 ・エグゼクティブ・サマリー ・細胞性腫瘍抗原p53の世界市場概要 ・細胞性腫瘍抗原p53の製造コスト構成分析 ・細胞性腫瘍抗原p53の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・細胞性腫瘍抗原p53の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・細胞性腫瘍抗原p53のセグメント分析（種類別） （COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他）...The global Cellular Tumor Antigen p53 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cellular Tumor Antigen p53 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cellular Tumor Antigen p53 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cellular Tumor Antigen p53 in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のポリペプチド薬市場 2019年
    DATA909X13371 / QYResearch / 2019年11月20日 / ※本調査レポートは、ポリペプチド薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、注射、経鼻投与、肺投与、経口投与、経皮投与に、用途別には、免疫調節薬（アレルギー感染＆免疫）、消化器系薬（胃腸型）、骨および結合組織型（甲状腺ホルモン薬）、婦人科または産科薬、腫瘍薬、尿系薬、代謝薬（インスリンおよびその他の血糖降下薬） にセグメント区分し、ポリペプチド薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ポリペプチド薬の世界市場概要 ・ポリペプチド薬の製造コスト構成分析 ・ポリペプチド薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ポリペプチド薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ポリペプチド薬のセグメント分析（種類別）...The global Polypeptide Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polypeptide Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polypeptide Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polypeptide Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Polypeptide Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆